Download Files:
DHODH-IN-23
SKU
HY-153112-10 mg
Category Reference compound
Tags Cancer, Dihydroorotate Dehydrogenase, Metabolic Enzyme/Protease
$100 – $950
Products Details
Product Description
– DHODH-IN-23 (Compound A) is an orally active DHODH inhibitor that can be used for the research of cancer[1].
Web ID
– HY-153112
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Molecular Formula
– C24H21ClFNO4
References
– [1]Srikant Viswanadha, et al. Compositions comprising a dhodh inhibitor for the treatment of acute myeloid leukemia. Patent WO2021079273A1.
CAS Number
– 1346705-53-0
Molecular Weight
– 441.88
Compound Purity
– 99.82
SMILES
– O=C(C1=C(C(NC2=C(C=C(C3=CC=CC(OCCCC)=C3)C=C2Cl)F)=O)C=CC=C1)O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 125 mg/mL (ultrasonic)
Target
– Dihydroorotate Dehydrogenase
Pathway
– Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.